Tandem Diabetes Care
TNDM
TNDM
330 hedge funds and large institutions have $3.63B invested in Tandem Diabetes Care in 2022 Q2 according to their latest regulatory filings, with 37 funds opening new positions, 150 increasing their positions, 109 reducing their positions, and 79 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
more repeat investments, than reductions
Existing positions increased: | Existing positions reduced:
more ownership
Funds ownership: →
less funds holding
Funds holding: →
47% less capital invested
Capital invested by funds: $6.84B → $3.63B (-$3.21B)
53% less first-time investments, than exits
New positions opened: 37 | Existing positions closed: 79
67% less funds holding in top 10
Funds holding in top 10: 6 → 2 (-4)
Holders
330
Holding in Top 10
2
Calls
$45.5M
Puts
$24.7M
Top Buyers
| 1 | +$104M | |
| 2 | +$90.2M | |
| 3 | +$39.9M | |
| 4 |
BCM
Brown Capital Management
Baltimore,
Maryland
|
+$38.9M |
| 5 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$33.4M |
Top Sellers
| 1 | -$174M | |
| 2 | -$66.5M | |
| 3 | -$55.9M | |
| 4 |
Citadel Advisors
Miami,
Florida
|
-$38.5M |
| 5 |
Ameriprise
Minneapolis,
Minnesota
|
-$38.4M |